25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BMRA (Biomerica) Stock Analysis
Buy, Hold or Sell?

Let's analyze Biomerica together

I guess you are interested in Biomerica Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Biomerica’s Financial Insights
  • 📈 Technical Analysis (TA) – Biomerica’s Price Targets

I'm going to help you getting a better view of Biomerica Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biomerica Inc

I send you an email if I find something interesting about Biomerica Inc.

1. Quick Overview

1.1. Quick analysis of Biomerica (30 sec.)










1.2. What can you expect buying and holding a share of Biomerica? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.39
Expected worth in 1 year
$-1.35
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-1.75
Return On Investment
-58.4%

For what price can you sell your share?

Current Price per Share
$2.99
Expected price per share
$2.08 - $4.24
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biomerica (5 min.)




Live pricePrice per Share (EOD)
$2.99
Intrinsic Value Per Share
$-3.08 - $0.14
Total Value Per Share
$-2.69 - $0.53

2.2. Growth of Biomerica (5 min.)




Is Biomerica growing?

Current yearPrevious yearGrowGrow %
How rich?$6.5m$11.7m-$5.1m-77.9%

How much money is Biomerica making?

Current yearPrevious yearGrowGrow %
Making money-$5.9m-$7.1m$1.1m19.4%
Net Profit Margin-110.4%-133.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Biomerica (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#223 / 289

Most Revenue
#199 / 289

Most Profit
#213 / 289

Most Efficient
#222 / 289
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biomerica?

Welcome investor! Biomerica's management wants to use your money to grow the business. In return you get a share of Biomerica.

First you should know what it really means to hold a share of Biomerica. And how you can make/lose money.

Speculation

The Price per Share of Biomerica is $2.99. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biomerica.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biomerica, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.39. Based on the TTM, the Book Value Change Per Share is $-0.44 per quarter. Based on the YOY, the Book Value Change Per Share is $0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biomerica.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.36-11.9%-0.36-11.9%-0.50-16.9%-0.41-13.6%-0.40-13.3%-0.28-9.3%
Usd Book Value Change Per Share-0.44-14.6%-0.44-14.6%0.175.7%-0.13-4.3%-0.01-0.3%-0.04-1.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.44-14.6%-0.44-14.6%0.175.7%-0.13-4.3%-0.01-0.3%-0.04-1.4%
Usd Price Per Share0.58-0.58-1.37-1.82-3.11-2.69-
Price to Earnings Ratio-1.63--1.63--2.72--4.71--9.80--13.37-
Price-to-Total Gains Ratio-1.33--1.33-7.99--7.78--4.50--23.31-
Price to Book Ratio1.48-1.48-1.65-2.82-3.56-3.93-
Price-to-Total Gains Ratio-1.33--1.33-7.99--7.78--4.50--23.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.99
Number of shares334
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.44-0.01
Usd Total Gains Per Share-0.44-0.01
Gains per Quarter (334 shares)-145.79-2.69
Gains per Year (334 shares)-583.14-10.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-583-5930-11-21
20-1166-11760-22-32
30-1749-17590-32-43
40-2333-23420-43-54
50-2916-29250-54-65
60-3499-35080-65-76
70-4082-40910-75-87
80-4665-46740-86-98
90-5248-52570-97-109
100-5831-58400-108-120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%12.024.00.033.3%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.08.00.020.0%17.018.01.047.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.036.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.08.00.020.0%17.018.01.047.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biomerica Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.436-0.4360%0.171-355%-0.127-71%-0.008-98%-0.041-91%
Book Value Per Share--0.3920.3920%0.828-53%0.626-37%0.810-52%0.695-44%
Current Ratio--3.5083.5080%6.579-47%4.925-29%6.374-45%6.647-47%
Debt To Asset Ratio--0.2880.2880%0.189+52%0.248+16%0.228+26%0.183+57%
Debt To Equity Ratio--0.4040.4040%0.233+74%0.334+21%0.300+35%0.233+73%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--11273647.66811273647.6680%26380348.530-57%28292590.233-60%40279212.694-72%29942843.971-62%
Eps---0.355-0.3550%-0.504+42%-0.406+14%-0.398+12%-0.277-22%
Ev To Ebitda Ratio---1.881-1.8810%-3.915+108%-5.928+215%-11.114+491%-16.754+791%
Ev To Sales Ratio--2.0822.0820%4.941-58%3.175-34%5.292-61%4.455-53%
Free Cash Flow Per Share---0.326-0.3260%-0.392+20%-0.256-21%-0.334+3%-0.228-30%
Free Cash Flow To Equity Per Share---0.330-0.3300%0.271-222%0.026-1364%0.098-437%0.040-919%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.142----------
Intrinsic Value_10Y_min---3.085----------
Intrinsic Value_1Y_max---0.176----------
Intrinsic Value_1Y_min---0.331----------
Intrinsic Value_3Y_max---0.384----------
Intrinsic Value_3Y_min---0.981----------
Intrinsic Value_5Y_max---0.417----------
Intrinsic Value_5Y_min---1.612----------
Market Cap7611822.400-28%9766647.6689766647.6680%19391348.530-50%24504784.566-60%36566184.694-73%27848894.571-65%
Net Profit Margin---1.104-1.1040%-1.337+21%-0.894-19%-0.786-29%-0.517-53%
Operating Margin---1.176-1.1760%-1.328+13%-0.915-22%-0.835-29%-0.533-55%
Operating Ratio--2.1762.1760%2.353-8%1.923+13%1.807+20%1.523+43%
Pb Ratio7.631+81%1.4821.4820%1.654-10%2.821-47%3.562-58%3.931-62%
Pe Ratio-8.414-415%-1.634-1.6340%-2.716+66%-4.713+188%-9.798+500%-13.370+718%
Price Per Share2.990+81%0.5810.5810%1.370-58%1.817-68%3.114-81%2.692-78%
Price To Free Cash Flow Ratio-9.185-415%-1.784-1.7840%-3.493+96%-24.475+1272%-19.234+978%-21.338+1096%
Price To Total Gains Ratio-6.850-415%-1.330-1.3300%7.992-117%-7.783+485%-4.499+238%-23.310+1652%
Quick Ratio--2.3222.3220%5.368-57%3.672-37%4.482-48%4.051-43%
Return On Assets---0.646-0.6460%-0.494-24%-0.513-21%-0.444-31%-0.346-47%
Return On Equity---0.907-0.9070%-0.609-33%-0.687-24%-0.585-35%-0.441-51%
Total Gains Per Share---0.436-0.4360%0.171-355%-0.127-71%-0.008-98%-0.041-91%
Usd Book Value--6591000.0006591000.0000%11724000.000-44%8879904.667-26%10015958.000-34%7369665.600-11%
Usd Book Value Change Per Share---0.436-0.4360%0.171-355%-0.127-71%-0.008-98%-0.041-91%
Usd Book Value Per Share--0.3920.3920%0.828-53%0.626-37%0.810-52%0.695-44%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--11273647.66811273647.6680%26380348.530-57%28292590.233-60%40279212.694-72%29942843.971-62%
Usd Eps---0.355-0.3550%-0.504+42%-0.406+14%-0.398+12%-0.277-22%
Usd Free Cash Flow---5476000.000-5476000.0000%-5552000.000+1%-3892956.000-29%-4328524.800-21%-2691541.800-51%
Usd Free Cash Flow Per Share---0.326-0.3260%-0.392+20%-0.256-21%-0.334+3%-0.228-30%
Usd Free Cash Flow To Equity Per Share---0.330-0.3300%0.271-222%0.026-1364%0.098-437%0.040-919%
Usd Market Cap7611822.400-28%9766647.6689766647.6680%19391348.530-50%24504784.566-60%36566184.694-73%27848894.571-65%
Usd Price Per Share2.990+81%0.5810.5810%1.370-58%1.817-68%3.114-81%2.692-78%
Usd Profit---5978000.000-5978000.0000%-7140000.000+19%-5883014.667-2%-5291426.800-11%-3305578.000-45%
Usd Revenue--5415000.0005415000.0000%5339000.000+1%9875136.333-45%8703429.400-38%7017587.300-23%
Usd Total Gains Per Share---0.436-0.4360%0.171-355%-0.127-71%-0.008-98%-0.041-91%
 EOD+3 -5MRQTTM+0 -0YOY+13 -243Y+6 -315Y+8 -2910Y+4 -34

3.3 Fundamental Score

Let's check the fundamental score of Biomerica Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.414
Price to Book Ratio (EOD)Between0-17.631
Net Profit Margin (MRQ)Greater than0-1.104
Operating Margin (MRQ)Greater than0-1.176
Quick Ratio (MRQ)Greater than12.322
Current Ratio (MRQ)Greater than13.508
Debt to Asset Ratio (MRQ)Less than10.288
Debt to Equity Ratio (MRQ)Less than10.404
Return on Equity (MRQ)Greater than0.15-0.907
Return on Assets (MRQ)Greater than0.05-0.646
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Biomerica Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.096
Ma 20Greater thanMa 503.069
Ma 50Greater thanMa 1003.226
Ma 100Greater thanMa 2003.304
OpenGreater thanClose3.020
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Biomerica Inc

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops, markets, and sells COVID-19 diagnostic tests to indicate if a person has been infected by COVID-19. The company was incorporated in 1971 and is headquartered in Irvine, California.

Fundamental data was last updated by Penke on 2025-08-23 12:13:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biomerica earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • A Net Profit Margin of -110.4% means that $-1.10 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biomerica Inc:

  • The MRQ is -110.4%. The company is making a huge loss. -2
  • The TTM is -110.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-110.4%TTM-110.4%0.0%
TTM-110.4%YOY-133.7%+23.3%
TTM-110.4%5Y-78.6%-31.8%
5Y-78.6%10Y-51.7%-26.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-110.4%-10.9%-99.5%
TTM-110.4%-10.0%-100.4%
YOY-133.7%-14.9%-118.8%
3Y-89.4%-13.7%-75.7%
5Y-78.6%-12.2%-66.4%
10Y-51.7%-12.2%-39.5%
4.3.1.2. Return on Assets

Shows how efficient Biomerica is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • -64.6% Return on Assets means that Biomerica generated $-0.65 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biomerica Inc:

  • The MRQ is -64.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -64.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-64.6%TTM-64.6%0.0%
TTM-64.6%YOY-49.4%-15.2%
TTM-64.6%5Y-44.4%-20.2%
5Y-44.4%10Y-34.6%-9.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-64.6%-1.7%-62.9%
TTM-64.6%-2.1%-62.5%
YOY-49.4%-3.3%-46.1%
3Y-51.3%-2.9%-48.4%
5Y-44.4%-2.5%-41.9%
10Y-34.6%-3.1%-31.5%
4.3.1.3. Return on Equity

Shows how efficient Biomerica is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • -90.7% Return on Equity means Biomerica generated $-0.91 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biomerica Inc:

  • The MRQ is -90.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -90.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-90.7%TTM-90.7%0.0%
TTM-90.7%YOY-60.9%-29.8%
TTM-90.7%5Y-58.5%-32.2%
5Y-58.5%10Y-44.1%-14.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-90.7%-2.0%-88.7%
TTM-90.7%-2.0%-88.7%
YOY-60.9%-4.0%-56.9%
3Y-68.7%-4.4%-64.3%
5Y-58.5%-4.3%-54.2%
10Y-44.1%-5.7%-38.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biomerica Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biomerica is operating .

  • Measures how much profit Biomerica makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • An Operating Margin of -117.6% means the company generated $-1.18  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biomerica Inc:

  • The MRQ is -117.6%. The company is operating very inefficient. -2
  • The TTM is -117.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-117.6%TTM-117.6%0.0%
TTM-117.6%YOY-132.8%+15.2%
TTM-117.6%5Y-83.5%-34.1%
5Y-83.5%10Y-53.3%-30.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-117.6%-18.2%-99.4%
TTM-117.6%-13.5%-104.1%
YOY-132.8%-15.3%-117.5%
3Y-91.5%-13.6%-77.9%
5Y-83.5%-11.4%-72.1%
10Y-53.3%-15.8%-37.5%
4.3.2.2. Operating Ratio

Measures how efficient Biomerica is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 2.18 means that the operating costs are $2.18 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biomerica Inc:

  • The MRQ is 2.176. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.176. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.176TTM2.1760.000
TTM2.176YOY2.353-0.177
TTM2.1765Y1.807+0.369
5Y1.80710Y1.523+0.284
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1761.320+0.856
TTM2.1761.308+0.868
YOY2.3531.221+1.132
3Y1.9231.288+0.635
5Y1.8071.312+0.495
10Y1.5231.320+0.203
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biomerica Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biomerica is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.51 means the company has $3.51 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biomerica Inc:

  • The MRQ is 3.508. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.508. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.508TTM3.5080.000
TTM3.508YOY6.579-3.072
TTM3.5085Y6.374-2.866
5Y6.37410Y6.647-0.272
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5082.474+1.034
TTM3.5082.594+0.914
YOY6.5792.697+3.882
3Y4.9252.885+2.040
5Y6.3743.528+2.846
10Y6.6473.426+3.221
4.4.3.2. Quick Ratio

Measures if Biomerica is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • A Quick Ratio of 2.32 means the company can pay off $2.32 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biomerica Inc:

  • The MRQ is 2.322. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.322. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.322TTM2.3220.000
TTM2.322YOY5.368-3.046
TTM2.3225Y4.482-2.160
5Y4.48210Y4.051+0.431
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3221.350+0.972
TTM2.3221.553+0.769
YOY5.3681.706+3.662
3Y3.6721.905+1.767
5Y4.4822.225+2.257
10Y4.0512.519+1.532
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biomerica Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biomerica assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biomerica to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.29 means that Biomerica assets are financed with 28.8% credit (debt) and the remaining percentage (100% - 28.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biomerica Inc:

  • The MRQ is 0.288. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.288. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.288TTM0.2880.000
TTM0.288YOY0.189+0.099
TTM0.2885Y0.228+0.060
5Y0.22810Y0.183+0.045
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2880.408-0.120
TTM0.2880.414-0.126
YOY0.1890.400-0.211
3Y0.2480.397-0.149
5Y0.2280.420-0.192
10Y0.1830.456-0.273
4.5.4.2. Debt to Equity Ratio

Measures if Biomerica is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • A Debt to Equity ratio of 40.4% means that company has $0.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biomerica Inc:

  • The MRQ is 0.404. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.404. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.404TTM0.4040.000
TTM0.404YOY0.233+0.171
TTM0.4045Y0.300+0.104
5Y0.30010Y0.233+0.067
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4040.631-0.227
TTM0.4040.646-0.242
YOY0.2330.605-0.372
3Y0.3340.640-0.306
5Y0.3000.649-0.349
10Y0.2330.769-0.536
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biomerica generates.

  • Above 15 is considered overpriced but always compare Biomerica to the Medical Devices industry mean.
  • A PE ratio of -1.63 means the investor is paying $-1.63 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biomerica Inc:

  • The EOD is -8.414. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.634. Based on the earnings, the company is expensive. -2
  • The TTM is -1.634. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.414MRQ-1.634-6.780
MRQ-1.634TTM-1.6340.000
TTM-1.634YOY-2.716+1.082
TTM-1.6345Y-9.798+8.164
5Y-9.79810Y-13.370+3.572
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-8.414-1.141-7.273
MRQ-1.634-1.287-0.347
TTM-1.634-1.277-0.357
YOY-2.716-2.876+0.160
3Y-4.713-1.561-3.152
5Y-9.798-2.137-7.661
10Y-13.370-1.811-11.559
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biomerica Inc:

  • The EOD is -9.185. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.784. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.784. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.185MRQ-1.784-7.401
MRQ-1.784TTM-1.7840.000
TTM-1.784YOY-3.493+1.709
TTM-1.7845Y-19.234+17.450
5Y-19.23410Y-21.338+2.105
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-9.185-1.848-7.337
MRQ-1.784-2.063+0.279
TTM-1.784-1.841+0.057
YOY-3.493-3.187-0.306
3Y-24.475-2.200-22.275
5Y-19.234-4.000-15.234
10Y-21.338-4.000-17.338
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biomerica is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.48 means the investor is paying $1.48 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biomerica Inc:

  • The EOD is 7.631. Based on the equity, the company is overpriced. -1
  • The MRQ is 1.482. Based on the equity, the company is underpriced. +1
  • The TTM is 1.482. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD7.631MRQ1.482+6.149
MRQ1.482TTM1.4820.000
TTM1.482YOY1.654-0.172
TTM1.4825Y3.562-2.080
5Y3.56210Y3.931-0.369
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD7.6312.280+5.351
MRQ1.4822.158-0.676
TTM1.4822.203-0.721
YOY1.6542.683-1.029
3Y2.8212.683+0.138
5Y3.5623.687-0.125
10Y3.9314.207-0.276
4.6.2. Total Gains per Share

2.4. Latest News of Biomerica Inc

Does Biomerica Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Biomerica Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-03
14:19
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home UseRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biomerica Inc.

4.8.1. Institutions holding Biomerica Inc

Institutions are holding 3.743% of the shares of Biomerica Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Geode Capital Management, LLC0.768801565833808032.1342
2025-03-31BlackRock Inc0.732014908100
2025-03-31Granahan Investment Management Inc..0.43190.002587968-570799-86.6466
2025-03-31Two Sigma Investments LLC0.2080.000142362423620
2025-03-31State Street Corp0.182803723100
2025-03-31Goss Wealth Management LLC0.14290.00012910000
2025-03-31TWO SIGMA SECURITIES, LLC0.11560.00223542-31653-57.3476
2025-06-30Vanguard Group Inc0.829902112710.0047
2025-03-31Northern Trust Corp0.101402066100
2025-03-31Group One Trading, LP0.09460192601922149284.6154
2025-03-31UBS Group AG0.08016288-6965-29.9531
2025-03-31HRT FINANCIAL LLC0.062012621-24033-65.5672
2025-03-31Susquehanna International Group, LLP0.0615012528-16893-57.4182
2025-03-31Hollencrest Securities, LLC0.0570.00031160000
2025-03-31NewEdge Investment Solutions0.04910.000110000100000
2025-03-31Atlantic Trust Group, LLC0.016203300-600-15.3846
2025-03-31Advisor Group Holdings, Inc.0.01470300030000
2025-03-31Atala Financial Inc0.00250.000250000
2025-03-31Bank of America Corp0.00170346185.4878
2025-06-30HARBOUR INVESTMENTS, INC.0.0049012500
Total 3.95750.0053657223-538261-81.9%

4.9.2. Funds holding Biomerica Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.57010.000114514-6613-31.3012
2025-06-30Fidelity Extended Market Index0.47330.00011204900
2025-06-30Fidelity Series Total Market Index0.168504289-1276-22.929
2025-06-30Spartan Extended Market Index Pool F0.09890.0001251800
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.01210247024700
2025-06-30Fidelity Total Market Index0.06750171900
2025-06-30Northern Trust Extended Eq Market Idx0.05090.000112961134700
2025-06-30NT Ext Equity Mkt Idx Fd - L0.05090.0001129600
2025-06-30Spartan Total Market Index Pool G0.04230107800
2025-06-30NT Ext Equity Mkt Idx Fd - NL0.03970.0001101100
2025-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.03080.0001785-2-0.2541
2025-06-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.01440.00013665417.3077
2025-07-31State St US Ttl Mkt Indx NL Cl A0.0059015000
2025-06-30Northern Trust Wilshire 50000.00560143125694.4444
2025-06-30BNYM Mellon SL Market Completion UC10.00480.0001123-1-0.8065
2025-06-30NT Quality SCC US Fund - L0.00240.00016100
2025-06-30NT Quality Small Cap Core0.00240.00016153662.5
2025-06-30Fidelity U.S. Equity Index Ins Trust0.000401000
Total 1.64090.001143939-4056-9.2%

5.3. Insider Transactions

Insiders are holding 10.133% of the shares of Biomerica Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-05-24Zackary S IraniBUY6212.88
2023-05-12Zackary S IraniBUY2129.36
2023-05-09Zackary S IraniBUY3711.12
2023-04-28Zackary S IraniBUY22510.72
2023-04-26Zackary S IraniBUY87510.08
2023-01-27Allen BarbieriBUY19223.52
2023-01-26Catherine CosteBUY27323.68
2023-01-24Zackary S IraniBUY25022.48
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-05-31. Currency in USD. All numbers in thousands.

Summary
Total Assets9,254
Total Liabilities2,663
Total Stockholder Equity6,591
 As reported
Total Liabilities 2,663
Total Stockholder Equity+ 6,591
Total Assets = 9,254

Assets

Total Assets9,254
Total Current Assets7,731
Long-term Assets1,523
Total Current Assets
Cash And Cash Equivalents 4,170
Net Receivables 947
Inventory 2,376
Other Current Assets 238
Total Current Assets  (as reported)7,731
Total Current Assets  (calculated)7,731
+/-0
Long-term Assets
Property Plant Equipment 943
Long Term Investments 165
Intangible Assets 212
Long-term Assets Other 203
Long-term Assets  (as reported)1,523
Long-term Assets  (calculated)1,523
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,204
Long-term Liabilities459
Total Stockholder Equity6,591
Total Current Liabilities
Short-term Debt 326
Accounts payable 288
Other Current Liabilities 1,505
Total Current Liabilities  (as reported)2,204
Total Current Liabilities  (calculated)2,119
+/- 85
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt459
Long-term Liabilities  (as reported)459
Long-term Liabilities  (calculated)459
+/-0
Total Stockholder Equity
Common Stock1,346
Retained Earnings -48,195
Accumulated Other Comprehensive Income -102
Other Stockholders Equity 53,542
Total Stockholder Equity (as reported)6,591
Total Stockholder Equity (calculated)6,591
+/-0
Other
Capital Stock1,346
Cash and Short Term Investments 4,170
Common Stock Shares Outstanding 16,822
Current Deferred Revenue85
Liabilities and Stockholders Equity 9,254
Net Debt -3,385
Net Invested Capital 6,591
Net Working Capital 5,527
Property Plant and Equipment Gross 3,247
Short Long Term Debt Total 785



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-05-312023-05-312022-05-312021-05-312020-05-312019-05-312018-05-312017-05-312016-05-312015-05-312014-05-312013-05-312012-05-312011-05-312010-05-312009-05-312008-05-312007-05-312006-05-312005-05-312004-05-312003-05-312002-05-312001-05-312000-05-311999-05-311998-05-311997-05-311996-05-311995-05-311994-05-311993-05-311992-05-311991-05-311990-05-311989-05-311988-05-311987-05-311986-05-31
> Total Assets 
7,500
6,300
4,800
3,800
9,000
7,300
6,400
6,300
6,300
5,800
6,100
7,400
7,500
7,800
6,735
5,347
5,277
5,548
5,568
5,791
2,428
3,225
5,108
5,152
5,015
4,955
5,571
6,395
6,470
6,124
5,727
5,018
5,223
5,245
17,260
11,819
11,374
14,454
9,254
9,25414,45411,37411,81917,2605,2455,2235,0185,7276,1246,4706,3955,5714,9555,0155,1525,1083,2252,4285,7915,5685,5485,2775,3476,7357,8007,5007,4006,1005,8006,3006,3006,4007,3009,0003,8004,8006,3007,500
   > Total Current Assets 
7,100
5,700
4,400
1,600
5,900
4,800
4,600
4,500
4,800
4,500
4,900
6,300
6,500
6,800
5,809
4,677
4,882
5,023
4,750
4,287
1,846
2,610
4,538
4,555
4,093
3,886
4,487
5,253
4,913
4,466
4,835
4,210
4,484
4,495
14,767
9,231
9,428
12,797
7,731
7,73112,7979,4289,23114,7674,4954,4844,2104,8354,4664,9135,2534,4873,8864,0934,5554,5382,6101,8464,2874,7505,0234,8824,6775,8096,8006,5006,3004,9004,5004,8004,5004,6004,8005,9001,6004,4005,7007,100
       Cash And Cash Equivalents 
6,200
4,700
3,700
0
0
200
300
300
800
700
600
1,700
1,800
1,700
634
136
329
525
352
352
120
517
2,022
1,596
1,055
989
1,077
2,470
1,509
1,088
1,889
1,225
1,205
687
8,641
4,199
5,917
9,719
4,170
4,1709,7195,9174,1998,6416871,2051,2251,8891,0881,5092,4701,0779891,0551,5962,0225171203523525253291366341,7001,8001,700600700800300300200003,7004,7006,200
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
100
99
42
3
13
26
8
3
1
0
100
0
165,324
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000165,324010001382613342991000000000000000
       Net Receivables 
400
300
200
200
2,500
2,000
1,300
1,500
1,500
1,600
1,800
1,500
1,600
1,600
1,702
1,544
1,507
1,663
1,517
1,722
561
505
614
641
1,018
747
1,201
872
1,448
1,112
969
1,060
800
1,455
1,766
1,455
774
722
947
9477227741,4551,7661,4558001,0609691,1121,4488721,2017471,0186416145055611,7221,5171,6631,5071,5441,7021,6001,6001,5001,8001,6001,5001,5001,3002,0002,500200200300400
       Inventory 
300
600
400
400
2,800
2,200
2,300
2,200
1,600
1,800
2,100
2,400
2,500
3,100
2,860
2,866
2,921
2,650
2,673
2,090
1,104
1,462
1,764
1,999
1,791
1,786
1,821
1,571
1,766
2,027
1,863
1,729
2,179
2,151
2,851
3,206
2,416
2,056
2,376
2,3762,0562,4163,2062,8512,1512,1791,7291,8632,0271,7661,5711,8211,7861,7911,9991,7641,4621,1042,0902,6732,6502,9212,8662,8603,1002,5002,4002,1001,8001,6002,2002,3002,2002,800400400600300
       Other Current Assets 
200
100
100
1,000
600
400
700
500
900
400
400
700
600
300
514
89
122
171
182
115
58
126
137
219
230
365
388
537
294
403
227
392
601
405
1,509
370
321
300
238
2383003213701,50940560139222740329453738836523021913712658115182171122895143006007004004009005007004006001,000100100200
   > Long-term Assets 
400
600
400
2,200
3,100
2,500
1,800
1,800
1,500
1,300
1,200
1,100
1,000
1,000
927
670
395
525
818
1,504
582
614
570
597
922
1,069
1,084
1,142
1,557
1,659
891
808
739
750
2,493
2,588
1,946
1,657
1,523
1,5231,6571,9462,5882,4937507398088911,6591,5571,1421,0841,0699225975706145821,5048185253956709271,0001,0001,1001,2001,3001,5001,8001,8002,5003,1002,200400600400
       Property Plant Equipment 
300
300
200
100
1,300
1,300
1,000
800
500
500
500
500
500
400
470
318
228
387
717
817
127
168
370
367
562
567
585
655
614
445
381
332
351
351
1,991
1,864
1,515
1,248
943
9431,2481,5151,8641,9913513513323814456146555855675623673701681278177173872283184704005005005005005008001,0001,3001,300100200300300
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
165
165
165
165
165
165
165
165
165
165
165
1651651651651651651651651651651650000000000000000000000000000
       Intangible Assets 
0
0
0
0
1,500
1,200
900
800
700
600
600
500
500
400
367
297
116
70
49
13
8
3
0
30
84
177
195
165
382
321
249
174
99
107
169
295
170
165
212
2121651702951691079917424932138216519517784300381349701162973674005005006006007008009001,2001,5000000
       Long-term Assets Other 
100
300
200
2,100
300
0
-100
200
300
200
100
100
0
200
89
55
51
68
52
673
447
444
65
201
80
48
79
71
36
57
56
95
113
127
168
264
96
79
203
203799626416812711395565736717948802016544444767352685155892000100100200300200-10003002,100200300100
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
359
670
41
41
0
0
0
0
0
0
0
000000041416703590000000000000000000000000000
> Total Liabilities 
1,400
1,700
700
500
4,400
4,800
4,100
3,500
3,000
2,600
2,000
1,500
1,300
1,600
1,828
1,827
1,981
2,302
2,054
2,258
1,365
1,472
1,224
804
952
625
592
560
556
524
506
529
897
1,264
3,047
2,592
3,050
2,730
2,663
2,6632,7303,0502,5923,0471,2648975295065245565605926259528041,2241,4721,3652,2582,0542,3021,9811,8271,8281,6001,3001,5002,0002,6003,0003,5004,1004,8004,4005007001,7001,400
   > Total Current Liabilities 
1,200
1,500
500
500
3,200
4,800
4,100
3,400
3,100
1,600
1,700
1,500
1,400
1,600
1,828
1,732
1,636
2,048
2,054
2,258
1,356
1,412
1,109
724
917
625
592
560
556
524
506
529
897
1,264
1,477
1,300
2,011
1,945
2,204
2,2041,9452,0111,3001,4771,2648975295065245565605926259177241,1091,4121,3562,2582,0542,0481,6361,7321,8281,6001,4001,5001,7001,6003,1003,4004,1004,8003,2005005001,5001,200
       Short-term Debt 
0
0
0
0
1,600
2,600
2,200
2,200
1,800
400
500
400
100
200
160
140
96
59
317
476
265
172
100
42
45
35
43
0
0
0
0
0
0
0
212
656
682
297
326
32629768265621200000004335454210017226547631759961401602001004005004001,8002,2002,2002,6001,6000000
       Accounts payable 
0
0
0
400
1,600
1,400
1,500
700
600
600
700
700
800
1,000
1,314
931
906
1,280
983
1,083
581
666
474
264
402
246
188
282
386
357
326
336
656
1,000
833
431
736
344
288
2883447364318331,0006563363263573862821882464022644746665811,0839831,2809069311,3141,0008007007006006007001,5001,4001,600400000
       Other Current Liabilities 
1,200
1,500
500
100
0
800
400
500
700
600
500
400
500
400
354
661
326
708
754
699
511
573
536
681
470
343
227
278
170
167
180
192
241
265
432
213
849
1,244
1,505
1,5051,24484921343226524119218016717027822734347068153657351169975470832666135440050040050060070050040080001005001,5001,200
   > Long-term Liabilities 
200
200
200
0
1,200
100
100
100
-100
1,000
300
300
-100
0
0
95
345
255
0
0
9
60
115
81
35
451,569
0
0
0
0
0
8
0
1,000
1,570
1,292
1,038
785
459
4597851,0381,2921,5701,0000800000451,5693581115609002553459500-1003003001,000-1001001001001,2000200200200
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
359
670
41
41
0
0
0
0
0
0
0
000000041416703590000000000000000000000000000
> Total Stockholder Equity
6,100
4,600
4,100
3,300
2,800
1,800
1,300
1,200
1,600
1,400
2,000
3,600
3,700
3,800
2,796
1,473
1,211
1,100
926
1,053
1,064
1,753
3,884
4,348
4,063
4,330
4,979
5,835
5,914
5,601
5,220
4,489
4,326
3,981
14,213
9,227
8,325
11,724
6,591
6,59111,7248,3259,22714,2133,9814,3264,4895,2205,6015,9145,8354,9794,3304,0634,3483,8841,7531,0641,0539261,1001,2111,4732,7963,8003,7003,6002,0001,4001,6001,2001,3001,8002,8003,3004,1004,6006,100
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
300
366
391
438
446
460
460
461
476
519
530
533
549
556
582
603
605
654
681
711
774
939
985
1,029
1,346
1,346
1,3461,3461,0299859397747116816546056035825565495335305194764614604604464383913663000000000000000
   Retained Earnings -48,195-42,217-35,077-28,395-21,926-19,587-17,194-15,728-14,819-13,319-12,988-12,772-13,309-13,858-14,015-13,684-14,038-15,748-16,285-16,515-16,677-16,454-16,189-15,768-13,096-9,200-9,100-9,300-9,700-10,200-10,200-10,300-9,900-8,900-7,900-7,300-6,400-6,000-4,700
   Accumulated Other Comprehensive Income 
-700
-900
-900
-900
-2,600
-2,600
-2,400
-2,600
-2,600
-2,500
-2,700
-2,600
-2,600
-2,800
-4
-10
-20
-10
18
1
-177
-230
-4
-2
-4
-4
-6
-9
-10
-12
-14
-16
-26
-37
-40
-48
-74
-110
-102
-102-110-74-48-40-37-26-16-14-12-10-9-6-4-4-2-4-230-177118-10-20-10-4-2,800-2,600-2,600-2,700-2,500-2,600-2,600-2,400-2,600-2,600-900-900-900-700
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,309
18,327
19,400
19,552
20,844
22,830
0
36,685
0
0
0
00036,685022,83020,84419,55219,40018,32718,3090000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000
   Other Stockholders Equity 
11,500
11,500
11,400
11,500
13,300
13,300
13,600
14,100
14,400
14,100
14,400
15,500
15,400
12,700
15,529
16,860
16,982
17,117
17,125
17,107
17,064
17,255
17,407
17,503
17,549
17,643
17,738
18,034
18,309
18,327
19,400
19,552
20,834
22,830
35,214
38,837
42,447
52,705
53,542
53,54252,70542,44738,83735,21422,83020,83419,55219,40018,32718,30918,03417,73817,64317,54917,50317,40717,25517,06417,10717,12517,11716,98216,86015,52912,70015,40015,50014,40014,10014,40014,10013,60013,30013,30011,50011,40011,50011,500



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-05-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue5,415
Cost of Revenue-4,804
Gross Profit611611
 
Operating Income (+$)
Gross Profit611
Operating Expense-6,978
Operating Income-6,367-6,367
 
Operating Expense (+$)
Research Development1,491
Selling General Administrative5,487
Selling And Marketing Expenses0
Operating Expense6,9786,978
 
Net Interest Income (+$)
Interest Income431
Interest Expense-0
Other Finance Cost-0
Net Interest Income431
 
Pretax Income (+$)
Operating Income-6,367
Net Interest Income431
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,936-6,798
EBIT - interestExpense = -6,367
-5,936
-5,978
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-6,367-5,936
Earnings Before Interest and Taxes (EBITDA)-5,993
 
After tax Income (+$)
Income Before Tax-5,936
Tax Provision-42
Net Income From Continuing Ops-5,978-5,978
Net Income-5,978
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses11,782
Total Other Income/Expenses Net431-431
 

Technical Analysis of Biomerica
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biomerica. The general trend of Biomerica is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biomerica's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Biomerica Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biomerica Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.6 < 4.2099 < 4.24.

The bearish price targets are: 2.53 > 2.52 > 2.08.

Know someone who trades $BMRA? Share this with them.👇

Biomerica Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biomerica Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biomerica Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biomerica Inc. The current macd is -0.08803761.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biomerica price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biomerica. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biomerica price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biomerica Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiomerica Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biomerica Inc. The current adx is 11.93.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biomerica shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Biomerica Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biomerica Inc. The current sar is 3.31160974.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biomerica Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biomerica Inc. The current rsi is 46.10. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Biomerica Inc Daily Relative Strength Index (RSI) ChartBiomerica Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biomerica Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biomerica price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biomerica Inc Daily Stochastic Oscillator ChartBiomerica Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biomerica Inc. The current cci is -28.10746657.

Biomerica Inc Daily Commodity Channel Index (CCI) ChartBiomerica Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biomerica Inc. The current cmo is -5.15691403.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biomerica Inc Daily Chande Momentum Oscillator (CMO) ChartBiomerica Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biomerica Inc. The current willr is -48.31460674.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biomerica is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biomerica Inc Daily Williams %R ChartBiomerica Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biomerica Inc.

Biomerica Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biomerica Inc. The current atr is 0.26155147.

Biomerica Inc Daily Average True Range (ATR) ChartBiomerica Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biomerica Inc. The current obv is 508,874,960.

Biomerica Inc Daily On-Balance Volume (OBV) ChartBiomerica Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biomerica Inc. The current mfi is 4.33244937.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Biomerica Inc Daily Money Flow Index (MFI) ChartBiomerica Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biomerica Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-08-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-09-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Biomerica Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biomerica Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.096
Ma 20Greater thanMa 503.069
Ma 50Greater thanMa 1003.226
Ma 100Greater thanMa 2003.304
OpenGreater thanClose3.020
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biomerica with someone you think should read this too:
  • Are you bullish or bearish on Biomerica? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biomerica? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biomerica Inc

I send you an email if I find something interesting about Biomerica Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biomerica Inc.

Receive notifications about Biomerica Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.